Sichuan Hebang Biotechnology Hits Day High with Strong 3.94% Intraday Surge

Sichuan Hebang Biotechnology Co., Ltd. has experienced a notable increase of 3.94% on March 6, 2026, reaching an intraday high of CNY 2.94. This performance stands in contrast to the China Shanghai Composite, which recorded a modest gain of 0.38% on the same day. Over the past month, Sichuan Hebang has shown a significant upward trend, with a 18.85% increase, while the broader market has only managed a 1.44% rise. Year-to-date, the stock has performed well, boasting a 28.32% increase compared to the China Shanghai Composite's 3.91%. However, the company has faced challenges in the longer term, with a 57.61% increase over the past year, despite a decline in net profit and operating profit over the last five years. Sichuan Hebang operates within the Chemicals & Petrochemicals industry and holds a market capitalization of CNY 21,018 million. Despite its recent gains, the company has reported negative results for the last ten consecutive quarters, indicating a complex financial landscape.